Journalists working on stories related to high-risk pregnancies or the Society for Maternal-Fetal Medicine can contact Greg Phillips, Director of Communications, at press@smfm.org for referrals to MFM experts and to request additional information. The press office is open Monday through Friday from 9:00 AM to 5:00 PM ET.
We must help our patients understand all their reproductive care options, especially considering ongoing abortion restrictions and barriers. Continue Reading
Maternal-fetal medicine subspecialists (MFMs) should use their expertise to improve maternal safety by maximizing patient access to the full range of reproductive healthcare under current state abortion restrictions, according to the Society for Maternal-Fetal Medicine (SMFM). Continue Reading
HDPs, including preeclampsia, superimposed preeclampsia, chronic hypertension, gestational hypertension, Hemolysis, Elevated Liver enzymes and Low Platelets (HELLP) syndrome, and eclampsia, are the leading cause of maternal and infant illness and death in the United States. Continue Reading
The 130+ undersigned medical, nursing, public health, and patient advocacy groups express our deep concern about the revised charter for the Advisory Committee on Immunization Practices (ACIP) published on April 9. Continue Reading
A novel artificial intelligence (AI) model accurately detected the presence of placenta accreta spectrum (PAS), a dangerous pregnancy condition that often goes undetected with current screening methods, according to new research presented today at the SMFM 2026 Pregnancy Meeting. Continue Reading
Prescribing daily aspirin at the first prenatal visit to all pregnant patients was associated with an overall reduction in the development of severe preeclampsia, according to new research presented today at the Society for Maternal-Fetal Medicine (SMFM) 2026 Pregnancy Meeting™. Continue Reading
Pregnant patients who stopped taking their antidepressant medication during pregnancy were almost twice as likely to experience a mental health emergency compared with pregnant patients who continued taking their prescription, according to new research presented today at the SMFM Pregnancy Meeting. Continue Reading
The Society for Maternal-Fetal Medicine (SMFM) is pleased to announce that Jerasimos Ballas, MD, MPH; Catherine S. Eppes, MD, MPH; Moeun Son, MD, MSCI; and Sarahn M. Wheeler, MD, MHSc, have been elected to the SMFM Board. Continue Reading
Prepregnancy counseling, assembling multidisciplinary care teams, and referring to centers with expertise are critical in managing pregnant patients with heart failure to optimize maternal and newborn health outcomes, according to new guidance issued by SMFM. Continue Reading
The Society for Maternal-Fetal Medicine (SMFM) and the Society of OB/GYN Hospitalists (SOGH) are pleased to announce a focused commitment to our partnership that prioritizes the advancement of hospital-based obstetric care across the United States. Continue Reading
By: Adam K. Lewkowitz, MD, MPHS, and Emily S. Miller, MD, MPH On July 21, 2025, the Food and Drug Administration (FDA) convened a roundtable panelist discussion on the use of selective serotonin reuptake inhibitors (SSRIs), a class of antidepressant medication, in pregnancy. The FDA... Continue Reading
By Kristen A. Cagino, MD As physicians, we recognize that medical practice is built on a foundation of research. Discovering new therapies, navigating a global pandemic, and identifying the safest, evidence-based management strategy for complex conditions all rely on rigorous, well-designed... Continue Reading
